AstraZeneca PLC (AZN)
186.65
+12.25
(+7.02%)
USD |
NYSE |
Oct 30, 16:00
186.35
-0.30
(-0.16%)
Pre-Market: 20:00
AstraZeneca 30-Day Average Daily Volume : 2.950M for Oct. 30, 2026
30-Day Average Daily Volume Chart
Historical 30-Day Average Daily Volume Data
| Date | Value |
|---|---|
| October 30, 2026 | 2.950M |
| October 29, 2026 | 2.870M |
| October 28, 2026 | 2.873M |
| October 27, 2026 | 2.945M |
| October 26, 2026 | 2.947M |
| October 23, 2026 | 2.939M |
| October 22, 2026 | 2.891M |
| October 21, 2026 | 2.896M |
| October 20, 2026 | 2.962M |
| October 19, 2026 | 2.980M |
| October 16, 2026 | 3.005M |
| October 15, 2026 | 2.971M |
| October 14, 2026 | 2.934M |
| October 13, 2026 | 2.910M |
| October 12, 2026 | 2.908M |
| October 09, 2026 | 2.909M |
| October 08, 2026 | 2.921M |
| October 07, 2026 | 2.894M |
| October 06, 2026 | 2.928M |
| October 05, 2026 | 2.952M |
| October 02, 2026 | 2.983M |
| October 01, 2026 | 3.051M |
| September 30, 2026 | 3.066M |
| September 29, 2026 | 3.092M |
| September 28, 2026 | 3.092M |
| Date | Value |
|---|---|
| September 25, 2026 | 3.157M |
| September 24, 2026 | 3.208M |
| September 23, 2026 | 3.240M |
| September 22, 2026 | 3.253M |
| September 21, 2026 | 3.301M |
| September 18, 2026 | 3.327M |
| September 17, 2026 | 3.304M |
| September 16, 2026 | 3.410M |
| September 15, 2026 | 3.551M |
| September 14, 2026 | 3.997M |
| September 11, 2026 | 3.950M |
| September 10, 2026 | 3.951M |
| September 09, 2026 | 3.928M |
| September 08, 2026 | 3.957M |
| September 04, 2026 | 3.914M |
| September 03, 2026 | 3.879M |
| September 02, 2026 | 3.878M |
| September 01, 2026 | 3.824M |
| August 31, 2026 | 3.803M |
| August 28, 2026 | 3.786M |
| August 27, 2026 | 3.756M |
| August 26, 2026 | 3.774M |
| August 25, 2026 | 3.782M |
| August 24, 2026 | 3.787M |
| August 21, 2026 | 3.850M |
30-Day Average Daily Volume Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
30-Day Average Daily Volume Benchmarks
| GSK Plc | 5.319M |
| Johnson & Johnson | 7.270M |
| Eli Lilly & Co. | 2.448M |
| Merck & Co., Inc. | 9.901M |
| Novo Nordisk A/S | 13.38M |